Sunday, August 16, 2026

HomeHealth NewsFDA approves Zynyz as first-line treatment for advanced anal cancer

FDA approves Zynyz as first-line treatment for advanced anal cancer

- Advertisement -

The U.S. Food and Drug Administration has approved the humanized monoclonal antibody Zynyz (retifanlimab-dlwr) as the first first-line treatment for advanced anal cancer.

Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed